Release [print-friendly version]
National Assessment Finds Deaths and Treatment Admissions Involving Controlled Prescription Medications Increasing; Abuse Most Prevalent Among Young Adults
Newly Confirmed Drug Czar, DEA, NDIC to Hold Media Availability on Wednesday, May 20th
WASHINGTON–Gil Kerlikowske, Director of National Drug Control Policy, will release a report on the diversion and abuse of prescription drugs on Wednesday, May 20th at the National Methamphetamine Pharmaceutical Initiative (NMPI) in Nashville, Tennessee. The report finds pharmaceutical crimes pose a serious threat to public health and safety, with unintentional overdoses and treatment admissions involving prescription opioids increasing significantly over a similar four-year period.
The National Prescription Drug Threat Assessment (NPDTA) synthesizes reports and data from law enforcement and public health officials to evaluate the threat posed by the distribution, diversion, and abuse of controlled prescription drugs in the United States. Pain relievers, mostly prescription opioids, are among the most widely diverted and abused prescription medications. Young adults – aged 18 to 25 – are the most prevalent abusers of these drugs, with abuse also occurring among teens, adults, and the elderly.
Director Kerlikowske will release the report to over 300 law enforcement officials attending NMPI, an annual conference to address anti-methamphetamine and pharmaceutical diversion through strategy development, intelligence sharing, and training.
NPDTA was produced by the National Drug Intelligence Center (NDIC) and the Drug Enforcement Administration (DEA) at the request of the Office of National Drug Control Policy.
Who: Gil Kerlikowske, Director of National Drug Control Policy
WHAT: Media Availability at NMPI
WHEN: WEDNESDAY, MAY 20, 2008 at 10 A.M
WHERE: Gaylord Opryland Hotel